NIHR Academic Clinical Lecturer in General Adult Psychiatry at the University of Southampton
Placebo Effects | Affective and Anxiety Disorders
nathanhuneke.netlify.app
Nathan Huneke
We might finally get chaos under Ed Miliband
It was a real privilege to be invited to present on treatment-resistance in anxiety disorders at the Psychiatry Masterclass 2025 at the Conrad Dubai. Many thanks to the organising and scientific committees for inviting me!
It was great to be there with such excellent speakers!
REGISTER NOW for #BAP2026 Summer Meeting in Birmingham, 19th - 22nd July. For more information and to register go to
Our new Insights article out now in European Neuropsychopharmacology
We argue that poor control conditions in digital therapeutics trials risk misleading efficacy claims.
Let’s raise the bar for DTx trial design.
🔗 authors.elsevier.com/a/1l-8p,L21E...
@ecnp.eu
#DTx #MentalHealth #ClinicalTrials
We are accepting proposals for symposia from BAP members for the #BAP2027 Summer Meeting which will be held in Newcastle. Deadline 6th March. For more information and to submit a proposal go to
🎥 Two new #SFB289 #webinars are uploaded on our YouTube channel! 🎥
In September 2025, @nathanhuneke.bsky.social presented his work on placebo effects in psychiatric disorders: youtu.be/Z1pyhXSV5RE
It was great to present on placebo and nocebo effects in depressive and anxiety disorders in an educational update session at the ECNP Congress. Many thanks to the educational committee for inviting me! @ecnp.eu
Great to collaborate on this with @hvansteenbergen.bsky.social! We found evidence that endogenous opioids mediate attentional broadening after receiving rewards.
I’m guest editing a new BMC Psychiatry Collection on #placebo and #nocebo effects in psychiatry.
We’re looking for work on expectancy mechanisms, communication, and implications for clinical practice + trials.
Details: link.springer.com/collections/...
@sfb-trr-289.bsky.social
